Recent developments in the management of detrusor overactivity.
about
Beta-3 adrenergic receptor agonist for adult with overactive bladderDiagnosis of interstitial cystitis/ painful bladder syndrome in patients with overactive bladder symptomsCharacterization of a novel ATP-sensitive K+ channel opener, A-251179, on urinary bladder relaxation and cystometric parameters.AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder.Origin of spontaneous activity in neonatal and adult rat bladders and its enhancement by stretch and muscarinic agonistsCost effectiveness of mirabegron compared with tolterodine extended release for the treatment of adults with overactive bladder in the United KingdomEfficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trialOveractive bladder.Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in CanadaDiagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity.The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.A phase II dose-ranging study of mirabegron in patients with overactive bladderOutcomes associated with pharmacotherapy in overactive bladder.OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.A proof-of-concept study: mirabegron, a new therapy for overactive bladder.Morphological changes in the salivary acini after in vivo cholinergic stimulation.Persistence and adherence with mirabegron vs antimuscarinics in overactive bladder: Retrospective analysis of a UK General Practice prescription database.
P2860
Q24187596-11DB9573-2618-4C0D-932B-55D453B30E9DQ24676200-1EF1892F-A7B5-41E0-8179-6B3C7BEA6A2FQ34003601-53DABC20-D58F-4C13-BF33-B0E40700E7F3Q34112974-F26A757F-01B9-445D-9695-BBF3AED0A26BQ34548809-944CA5C4-E6E7-447F-ACD6-3DACA1FF8F49Q34990256-3F2B69C0-4CA5-405C-8F80-F2CE3D37E7D7Q34991783-43EE55D1-F87F-4050-8A22-F5C79DCB57EFQ36226387-ABF4E07A-C4C8-41B6-9B97-EE5F908C14E5Q36326096-A2A80369-2729-4BC1-A020-EE09E4C4E982Q36395035-D9726364-4ED2-496C-8073-C147CC2ABD37Q36428476-66C0F991-ABD5-44CE-A2D3-13A01DD63A2BQ37100337-C111DD9D-94B8-4799-9173-B31E2107BA1CQ37609155-3AC8B410-66C5-4EB4-8A3E-919A27BBCADCQ38669033-A2CE5DB5-48C4-470B-99EA-F43B64C81880Q44526404-2A911CE6-7B4E-42A2-BCD1-AEE3B423F066Q46255910-73811953-0CAE-4A55-92AE-2CBFF90D2293Q48347597-AF93E77C-6BC4-40AF-A8B7-E9965F0C3588
P2860
Recent developments in the management of detrusor overactivity.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recent developments in the management of detrusor overactivity.
@ast
Recent developments in the management of detrusor overactivity.
@en
type
label
Recent developments in the management of detrusor overactivity.
@ast
Recent developments in the management of detrusor overactivity.
@en
prefLabel
Recent developments in the management of detrusor overactivity.
@ast
Recent developments in the management of detrusor overactivity.
@en
P2093
P1476
Recent developments in the management of detrusor overactivity.
@en
P2093
Lucy Templeman
Russell Chess-Williams
Vivek Kumar
P304
P356
10.1097/00042307-200307000-00004
P577
2003-07-01T00:00:00Z